Merle Ferguson sold $401k of BFNH
director at BIOFORCE NANOSCIENCES HOLDINGS, INC.. 26,700,000 shares at an average of $0.02, traded Apr 22, 2026, filed Sep 2, 2026.
Score components
- +15RoleDirector
- +16Trade size$400k at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001091818-26-000134, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | GGift Common Stock; Par Value $0.001 | +20,580,000 | $0.01 | $144k | 22,568,000 | 41 d ago |
| Apr 20, 2026 | GGift Common Stock; Par Value $0.001 | +4,132,000 | $0.00 | $4,132 | 26,700,000 | 41 d ago |
| Apr 22, 2026 | SOpen-market sale Common Stock; Par Value $0.001 | -26,700,000 | $0.02 | $401k | 0 | 41 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.